Inotersen

FDA APPROVAL DATE: 10/05/2018

CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Adenosine, Aspirin, Clopidogrel, Heparin, Prasugrel, Ticagrelor, Ticlopidine, Warfarin

PREGNANCY CATEGORY: N/A
no data on the associated developmental risk

THROMBOCYTOPENIA AND GLOMERULONEPHRITIS

See full prescribing information for complete boxed warning

Our database has 26 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
RENAL
HEMATOLOGIC
LOCAL
OTHER


Page last updated 10/09/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric